Literature DB >> 7768967

Frequent loss of the short arm of chromosome 9 in resected non-small-cell lung cancers from Japanese patients and its association with squamous cell carcinoma.

Y Kishimoto1, K Sugio, T Mitsudomi, T Oyama, A K Virmani, D D McIntire, A F Gazdar.   

Abstract

We analyzed 87 Japanese non-small-cell lung carcinomas (NSCLC) including 30 squamous cell, 51 adenocarcinomas and 6 large-cell carcinomas for loss of heterozygosity (LOH) on the short arm of chromosome 9, and we correlated our findings with clinicopathological features. We used four polymorphic microsatellite markers on 9p (interferon A gene, D9S171, D9S126, and D9S169), which flank the critical region (9p21-22) involved in lung cancer. We observed alterations of DNA sequences at 9p in NSCLC (27 of 82 informative cases or 33%). Concordance among the four markers was high (87%), indicating that the deletions often were relatively large. The 27 genetic alterations observed on 9p include 26 examples of LOH, 1 homozygous deletion, and 1 case with LOH and evidence of microsatellite alteration characterized by shift in band mobility. We noted a high frequency of LOH at 9p especially in squamous cell carcinoma (17 of 29 informative cases or 59%), and in poorly differentiated NSCLC (12 of 23 informative cases or 52%). There was no correlation between LOH at 9p and the other clinical parameters, including survival, gender, tumor size and the presence of regional or distant metastases. In contrast to other reports, we found only rare instances of homozygous deletions (1%) and microsatellite alteration showed as a mobility shift (1%). Our findings demonstrate that LOH at the short arm of chromosome 9 is correlated with squamous cell and poorly differentiated carcinomas in Japanese patients with NSCLC.

Entities:  

Mesh:

Year:  1995        PMID: 7768967     DOI: 10.1007/BF01209596

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

1.  Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer.

Authors:  J Whang-Peng; T Knutsen; A Gazdar; S M Steinberg; H Oie; I Linnoila; J Mulshine; M Nau; J D Minna
Journal:  Genes Chromosomes Cancer       Date:  1991-05       Impact factor: 5.006

2.  Nucleotide repeats. Slippery DNA and diseases.

Authors:  T A Kunkel
Journal:  Nature       Date:  1993-09-16       Impact factor: 49.962

3.  A challenge to p16 gene as a major tumor suppressor.

Authors:  J Marx
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

4.  Cytogenetics of non-small cell lung cancer: analysis of consistent non-random abnormalities.

Authors:  R Lukeis; L Irving; M Garson; S Hasthorpe
Journal:  Genes Chromosomes Cancer       Date:  1990-07       Impact factor: 5.006

5.  Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.

Authors:  J Q Cheng; S C Jhanwar; Y Y Lu; J R Testa
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

6.  Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism.

Authors:  M H Jones; Y Nakamura
Journal:  Genes Chromosomes Cancer       Date:  1992-07       Impact factor: 5.006

7.  Paraffin wax-embedded material as a source of DNA for the detection of somatic genetic changes.

Authors:  V Sundaresan; P Ganly; P Hasleton; N M Bleehen; P Rabbitts
Journal:  J Pathol       Date:  1993-01       Impact factor: 7.996

8.  Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome.

Authors:  P Peltomäki; R A Lothe; L A Aaltonen; L Pylkkänen; M Nyström-Lahti; R Seruca; L David; R Holm; D Ryberg; A Haugen
Journal:  Cancer Res       Date:  1993-12-15       Impact factor: 12.701

9.  Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma.

Authors:  P G Pelicci; D M Knowles; I Magrath; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

10.  Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.

Authors:  T Mitsudomi; T Oyama; T Kusano; T Osaki; R Nakanishi; T Shirakusa
Journal:  J Natl Cancer Inst       Date:  1993-12-15       Impact factor: 13.506

View more
  3 in total

1.  Molecular biological markers and micrometastasis in resected non-small-cell lung cancer. Prognostic implications.

Authors:  T Osaki; T Oyama; M Inoue; C D Gu; M Kodate; M Aikawa; T So; M Mizukami; T Mitsudomi; K Yasumoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-09

2.  Prognostic impact of telomerase activity in non-small cell lung cancers.

Authors:  S Taga; T Osaki; A Ohgami; H Imoto; K Yasumoto
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

3.  Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.

Authors:  J K Field; E M Neville; M P Stewart; A Swift; T Liloglou; J M Risk; H Ross; J R Gosney; R J Donnelly
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.